Artha Sootra - Company Dashboard

Governance Classic Home

Wockhardt LtdPharmaceuticalsINE049B01025Consolidated₹1899.00+31.00 (+1.66%)

Valuation

Market Cap₹30.86K Cr

TTM PE75.24x

Forward PE65.85x

PEG470.25

Book Value₹317.43

P/B5.98x

TTM EPS₹25.24

Fwd EPS₹28.84

TTM Revenue₹3.75K Cr

TTM PAT₹405.00 Cr

TTM EBITDA₹767.00 Cr

TTM EBIT₹539.00 Cr

Last Qtr PAT₹73.00 Cr

Last Qtr EBITDA₹173.00 Cr

Last Qtr EBIT₹118.00 Cr

Profitability

ROE7.85%

ROCE8.96%

TTM NPM10.80%

TTM EBITDA %20.45%

Curr OPM7.45%

Last OPM11.15%

Curr NPM—

Last NPM—

Curr EPS₹4.85

Last EPS₹6.55

Balance sheet

Equity₹81.00 Cr

Reserve₹5.08K Cr

Total Debt₹2,238.00 Cr

D/E0.43x

Interest %76.71%

Curr Interest₹56.00 Cr

Price / range

Close₹1899.00

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.66%

1W-0.75%

1M-8.87%

3M-6.11%

6M+33.26%

1Y+39.12%

2Y+45.24%

3Y+694.56%

5Y+331.15%

Diwali+33.56%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	580+52.6%	561	516	430	380	1,739
Other Income	21	33	55	27	30	137
Total Income	601+46.6%	594	571	457	410	1,876
Interest	48	43	41	50	44	176
Expenditure	-501-40.7%	-487	-439	-419	-356	-1,584
PBDT	0	0	0	0	0	0
EBITDA	174+54.0%	158	161	113	113	517
Depreciation	-47	-41	-43	-52	-45	-186
EBIT	127+86.8%	117	118	61	68	331
PBT	100+85.2%	107	167	28	54	317
Tax	0	0	0	0	0	0
Equity	81	81	81	81	0	81
OPM	16.64	18.01	29.25	6.13	14.21	16.90
Net Profit	100+85.2%	107	167	28	54	317
NPM	16.64	18.01	29.25	6.13	14.21	16.90
EPS	6.15+88.7%	6.62	10.29	1.73	3.26	19.54

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,739+24.0%	1,402+21.5%	1,154+7.6%	1,072-21.9%	1,372+39.0%	987.26
Other Income	137	55	41	67	38	40.73
Total Income	1,876+28.8%	1,457+21.9%	1,195+4.9%	1,139-19.2%	1,410+37.2%	1,027.99
Expenditure	-1,584-7.8%	-1,469+8.4%	-1,603-13.1%	-1,417+11.1%	-1,594-5.6%	-1,509.28
Interest	-176	-199	-237	-229	-273	-200.24
PBDT	0	0	0	0	0	0
EBITDA	517+72.3%	300+933.3%	-36-151.4%	70-68.5%	222+261.2%	-137.70
Depreciation	-186	-168	-176	-186	-171	-184.08
EBIT	331+150.8%	132+162.3%	-212-82.8%	-116-327.5%	51+115.8%	-321.78
PBT	317+2741.7%	-12+97.2%	-422+17.7%	-513-178.8%	-184+70.5%	-623.77
Tax	0	0	0	47	44	231.73
Equity	81	81	0	0	0	0
OPM (%)	16.90	-0.82	-35.00	-45.00	-13.00	-61.00
Net Profit	317+2741.7%	-12+97.2%	-422+9.4%	-466-232.9%	-140-123.6%	593.29
NPM (%)	16.90	-0.82	-35.00	-41.00	-10.00	58.00
EPS (Rs)	19.54	0+100.0%	-29.27+9.7%	-32.40-178.8%	-11.62-121.7%	53.57
CEPS	19.52	0	-29.27	-32.40	-11.62	53.34

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	969+23.9%	929	965	888	782	3,373
Other Income	11	31	45	25	21	111
Total Income	980+22.0%	960	1,010	913	803	3,484
Interest	56	52	50	60	55	213
Expenditure	-907-27.4%	-844	-843	-836	-712	-3,161
PBDT	0	0	0	0	0	0
EBITDA	173-2.8%	192	225	177	178	652
Depreciation	-55	-55	-53	-65	-53	-227
EBIT	118-5.6%	137	172	112	125	425
PBT	73-19.8%	116	189	67	91	238
Tax	0	-9	-25	-6	-9	-39
Equity	81	81	81	0	0	81
OPM	7.45	12.08	18.71	7.34	11.33	6.83
Net Profit	73-11.0%	107	164	61	82	199
NPM	7.45	11.15	16.24	6.68	10.21	5.71
EPS	4.85+0.8%	6.55	10.23	3.61	4.81	13.12

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	3,373+12.0%	3,012+7.6%	2,798+5.5%	2,651-17.9%	3,230+19.3%	2,708.30
Other Income	111	62	83	122	20	132.27
Total Income	3,484+13.3%	3,074+6.7%	2,881+3.9%	2,773-14.7%	3,250+14.4%	2,840.57
Expenditure	-3,161-2.3%	-3,090+6.0%	-3,287-5.9%	-3,103+10.8%	-3,478-6.5%	-3,266.43
Interest	-213	-254	-305	-302	-299	-249.08
PBDT	0	0	0	0	0	0
EBITDA	652+65.9%	393+907.7%	39-61.4%	101-66.1%	298+572.8%	-63.03
Depreciation	-227	-217	-223	-251	-247	-246.02
EBIT	425+141.5%	176+195.7%	-184-22.7%	-150-394.1%	51+116.5%	-309.05
PBT	238+1587.5%	-16+96.2%	-420+32.7%	-624-51.8%	-411+27.7%	-568.34
Tax	-39	-41	-52	3	132	271.61
Equity	81	81	0	0	0	0
OPM (%)	6.83	-0.52	-14.58	-22.50	-12.65	-20.01
Net Profit	199+449.1%	-57+87.9%	-472+24.0%	-621-122.6%	-279-140.5%	688.60
NPM (%)	5.71	-1.85	-16.38	-22.39	-8.58	24.24
EPS (Rs)	13.12	0+100.0%	-32.05+17.4%	-38.79-91.7%	-20.24-132.7%	61.95
CEPS	13.10	0	-32.05	-38.79	-20.24	61.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2017	Interim Dividend	10	17 Nov 2016
2015	Interim Dividend	20	13 Nov 2014
2014	Interim Dividend	5	17 Feb 2014
2014	Interim Dividend	5	07 Nov 2013
2013	Final Dividend	5	22 Aug 2013
2008	Final Dividend	2.5	17 Apr 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split